Market Closed - London S.E. 16:35:00 12/07/2024 BST 5-day change 1st Jan Change
14.5 GBX 0.00% Intraday chart for Belluscura plc -3.33% -36.96%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Jonathan Satchell to Step Down from His Role as a Non-Executive Director of Belluscura plc CI
Belluscura Raises GBP2 Million via Conditional Issue of Loan Notes, Share Subscription MT
Creo extends contract; Belluscura raises funds AN
Belluscura plc announced that it has received £1.71 million in funding CI
EARNINGS: Blue Star loss narrows; Heavitree Brewery profit down AN
Belluscura plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Belluscura Raises New Funds via New Investor Subscription MT
Belluscura sees "significant" interest in planned loan note placing AN
EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant AN
Belluscura plc announced that it expects to receive £2.4 million in funding CI
AIM WINNERS & LOSERS: Zenova scores NHS deal; Staffline "encouraged" AN
Belluscura sees financial hit from delay to closing TMT acquisition AN
AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist AN
Belluscura plc Provides Earnings Guidance for the Full Year 2024 CI
Belluscura Amasses 98% Stake in TMT Acquisition MT
Belluscura plc completed the acquisition of TMT Acquisition Plc. CI
TMT Acquisition Delists from London Bourse MT
Belluscura to Launch Mandatory Acquisition of Remaining TMT Shares MT
FTSE 100 Closes Lower as Equities Slid on U.S. Inflation Data DJ
Belluscura Enters Oxygen Concentrator Distribution Deal With US-based Sunset Healthcare MT
Belluscura plc Announces Implementation of Distribution Agreement with Sunset Healthcare Solutions CI
FTSE 100 Closes Down 0.3% Dragged by Miners, Financial Stocks DJ
Belluscura Declares TMT Acquisition Offer Unconditional MT
AIM WINNERS & LOSERS: Belluscura shares up as wraps up TMT takeover AN
Belluscura rises as TMT Acquisition takeover offer becomes unconditional AN
Chart Belluscura plc
More charts
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
0.1883 USD
Average target price
0.4474 USD
Spread / Average Target

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BELL Stock
  4. News Belluscura plc
  5. Belluscura Raises New Funds via New Investor Subscription